DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 88 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is 7.52 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,048,018 | +14.1% | 239,624 | +38.6% | 0.00% | – |
| Q1 2023 | $2,671,475 | -13.5% | 172,911 | -8.2% | 0.00% | – |
| Q4 2022 | $3,088,630 | -43.5% | 188,446 | -36.2% | 0.00% | -100.0% |
| Q3 2022 | $5,462,000 | +31.8% | 295,244 | -6.3% | 0.00% | -50.0% |
| Q2 2022 | $4,145,000 | +34.1% | 315,213 | -5.5% | 0.00% | – |
| Q1 2022 | $3,091,000 | -17.2% | 333,444 | -12.7% | 0.00% | -100.0% |
| Q4 2021 | $3,732,000 | -1.2% | 381,909 | +243.4% | 0.00% | – |
| Q3 2021 | $3,779,000 | -49.4% | 111,227 | -45.4% | 0.00% | -100.0% |
| Q2 2021 | $7,464,000 | +280.8% | 203,861 | +366.4% | 0.00% | – |
| Q1 2021 | $1,960,000 | -54.6% | 43,705 | -42.3% | 0.00% | – |
| Q4 2020 | $4,319,000 | -59.9% | 75,687 | -63.9% | 0.00% | -100.0% |
| Q3 2020 | $10,758,000 | +274.6% | 209,701 | +336.1% | 0.00% | +100.0% |
| Q2 2020 | $2,872,000 | -86.3% | 48,085 | -90.6% | 0.00% | -90.0% |
| Q1 2020 | $21,032,000 | +106.7% | 510,877 | +212.5% | 0.01% | +150.0% |
| Q4 2019 | $10,177,000 | -26.1% | 163,503 | -59.7% | 0.00% | -33.3% |
| Q3 2019 | $13,765,000 | +111.2% | 405,580 | +40.3% | 0.01% | +100.0% |
| Q2 2019 | $6,517,000 | -23.1% | 288,997 | -20.8% | 0.00% | -25.0% |
| Q1 2019 | $8,472,000 | -24.9% | 365,016 | -32.1% | 0.00% | -33.3% |
| Q4 2018 | $11,281,000 | -7.6% | 537,443 | +70.4% | 0.01% | +20.0% |
| Q3 2018 | $12,215,000 | +1030.0% | 315,462 | +1048.3% | 0.01% | +400.0% |
| Q2 2018 | $1,081,000 | +104.7% | 27,471 | +4.3% | 0.00% | – |
| Q1 2018 | $528,000 | -89.4% | 26,337 | -89.9% | 0.00% | -100.0% |
| Q3 2017 | $4,965,000 | – | 261,436 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $69,030,000 | 15.95% |
| SV Health Investors, LLC | 449,951 | $25,679,000 | 12.37% |
| Sunesis Advisors, LLC | 96,299 | $5,496,000 | 4.45% |
| Redmile Group, LLC | 4,437,968 | $253,275,000 | 3.07% |
| Consonance Capital Management LP | 484,671 | $27,660,000 | 2.58% |
| SECTORAL ASSET MANAGEMENT INC | 488,842 | $27,898,000 | 1.97% |
| Opaleye Management Inc. | 222,000 | $12,670,000 | 1.66% |
| Eversept Partners, LP | 246,240 | $14,052,917 | 1.65% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 38,620 | $2,204,000 | 1.28% |
| Avoro Capital Advisors LLC | 1,300,000 | $74,191,000 | 1.28% |